Abbott Laboratories
Statements
Balance Sheet
All figures as the change versus the prior period, in percent. Periods without a positive comparison base stay empty.
Tick rows to compare them in a chart (up to 4)
| Line item | 2014 | 2015 | 2016 | 2017 | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 | 2025 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| – | +0.5% | +25.0% | +38.6% | -11.9% | +1.1% | +6.9% | +3.6% | -1.0% | -1.6% | +11.2% | +6.5% | |
| – | -7.2% | +89.2% | -24.8% | -27.4% | +7.1% | +30.5% | +18.6% | +4.1% | -10.1% | +4.3% | +9.9% | |
| – | +23.1% | +272.3% | -49.5% | -59.1% | +0.4% | +77.2% | +43.3% | +0.8% | -30.2% | +10.4% | +11.9% | |
| – | +37.3% | +206.5% | -48.8% | -57.5% | +1.3% | +72.7% | +43.4% | -0.8% | -28.4% | +9.5% | +12.2% | |
| – | -4.7% | -5.0% | +61.6% | -1.3% | +4.7% | +18.2% | +1.1% | -4.1% | +5.6% | +5.5% | +14.5% | |
| – | -1.7% | -6.3% | +47.9% | +5.4% | +13.7% | +16.1% | +2.9% | +19.7% | +6.4% | -5.7% | +4.7% | |
| – | -3.5% | -0.4% | +33.3% | -0.6% | +6.3% | +12.3% | -0.8% | +2.3% | +23.1% | +4.1% | +10.3% | |
| – | -4.3% | -20.3% | +212.6% | -3.2% | -0.3% | +2.4% | -2.2% | -1.9% | +3.9% | -2.4% | +4.0% | |
| – | -10.3% | -18.4% | +373.1% | -11.8% | -10.1% | -13.2% | -13.8% | -17.9% | -15.7% | -24.6% | -16.9% | |
| – | +1.5% | +60.4% | +41.3% | -19.3% | +0.4% | +8.1% | -0.9% | -4.2% | -8.4% | -2.5% | +1.3% | |
| – | -12.8% | -27.5% | +33.8% | +1.1% | +20.5% | +9.6% | +10.1% | +18.2% | -10.6% | +2.3% | +16.5% | |
| – | -29.5% | -57.7% | -46.1% | -71.0% | +713.0% | -72.6% | +116.7% | +148.3% | -46.6% | +32.4% | +88.7% | |
| – | +1.6% | +9.0% | +103.9% | +23.9% | +9.3% | +21.3% | +11.7% | +4.5% | -6.8% | -2.3% | +1.1% | |
| – | +72.3% | +252.3% | +31.6% | -28.9% | -13.9% | +11.2% | -6.6% | -16.0% | -6.4% | -7.2% | -21.6% | |
| – | -1.5% | -3.2% | +50.4% | -1.2% | +1.8% | +5.5% | +9.2% | +2.5% | +5.2% | +23.5% | +9.4% | |
| – | +12.6% | -0.7% | -6.2% | +2.4% | +5.2% | +6.9% | +14.1% | +11.8% | +6.5% | +25.8% | +5.3% | |
| – | -1.4% | -1.5% | +17.9% | +1.2% | +0.6% | +0.3% | +0.2% | -1.4% | -0.9% | -0.1% | -0.1% |
Data as of: September 18, 2026 · Source: fundamental data & SEC filings (annual and quarterly reports, 10-K/10-Q)
Note: pure fact-based analysis, not investment advice and not a solicitation to buy or sell. All figures without guarantee.